Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-16-706589
Filing Date
2016-09-09
Accepted
2016-09-09 17:29:34
Documents
8
Period of Report
2016-10-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A d256976dpre14a.htm PRE 14A 210117
2 GRAPHIC g256976g27o48.jpg GRAPHIC 252537
3 GRAPHIC g256976img02.jpg GRAPHIC 142589
4 GRAPHIC g256976stp006a.jpg GRAPHIC 9962
5 GRAPHIC g256976stp006b.jpg GRAPHIC 7972
6 GRAPHIC g256976txpg004a.jpg GRAPHIC 1716
7 GRAPHIC g256976txpg004b.jpg GRAPHIC 1043
8 GRAPHIC g256976txpg004c.jpg GRAPHIC 1266
  Complete submission text file 0001193125-16-706589.txt   786945
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33958 | Film No.: 161879535
SIC: 2834 Pharmaceutical Preparations